Biomatrix Ramping Up Synvisc Production; Analysts Boost 1999 Estimates
This article was originally published in The Gray Sheet
Executive Summary
A new U.S. manufacturing plant will allow Biomatrix to triple its syringe production capability by the fourth quarter of 1999, the company says.